Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 955E2 | — |
doctor did the titer to see how it took, it revealed he didn't take it; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of therapy non-responder in an adult male patient who received MMR (Priorix) (batch number 955E2, expiry date 13-SEP-2026) for prophylaxis. On 02-MAY-2025, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced therapy non-responder (Verbatim: doctor did the titer to see how it took, it revealed he didn't take it). The outcome of the therapy non-responder was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUL-2025 Pharmacist reported that he had an adult patient who got a vaccine, the Priorix back in May and when the doctor did the titer to see how it took. it revealed he didn't take it, and the patient wanted to know if they can get another vaccine. The reporter was trying to look at up in the literature and it did not really address, giving a second dose of this. And as a rule, you can, you know, usually an extra immunization is usually fine, but the reporter couldn't find out spelled out in the literature; no one had specifically asked him/her about this scenario, so, wondered if you that made the product, was there any unforeseen issues with doing that.
Test Name: titer; Result Unstructured Data: (Test Result:revealed he didn't take it,Unit:unknown,Normal Low:,Normal High:)